All News
All news
-
News Regeneron and Sanofi to present new analyses from Praluent injection trials
Presentations include results from ODYSSEY APPRISE, an open-label study in 16 European countries and Canada in patients with severe hypercholesterolemia at high cardiovascular risk. -
News EC approves first oral short-course treatment for highly active relapsing multiple sclerosis
Mavenclad has shown sustained clinical efficacy for up to 4 years with a maximum of 20 days of oral treatment over 2 years. -
News MedPharm strengthens management on back of US success
Appointments come as global leader in contract topical and transdermal pharmaceutical development benefits from increased revenues. -
News Otsuka and Mylan sign license agreement to commercialize delamanid for MDR-TB in high-burden countries
Mylan granted an exclusive license by Otsuka to prioritize access to Deltyba in South Africa and India. -
News FDA grants Priority Review to Genentech's emicizumab for Hemophilia A with inhibitors
Application based on positive results of Phase III study in adults and adolescents with hemophilia A with inhibitors and interim Phase III results in children. -
News Charles River Laboratories acquires Brains On-Line
Establishes Charles River as a premier source for CNS contract research services. -
News Novavax’ preclinical influenza nanoparticle study published in Vaccine
Data suggest that NanoFlu has the potential to elicit a broader, more robust immune response, resulting in greater protection than the market-leading licensed influenza vaccine in older adults. -
News Novartis and MMV launch patient trial in Africa for a novel compound against multidrug-resistant malaria
Compound has potential to be a game-changer in malaria elimination, rapidly clearing malaria infection, including resistant strains, and blocking parasite transmission. -
News Bavarian Nordic closes transaction with Janssen Pharmaceuticals
Collaboration grants Janssen the exclusive rights to Bavarian Nordic’s MVA-BN technology for two additional programs, targeting vaccines against hepatitis B virus and the human immunodeficiency virus. -
News Amgen and Humana partner for improved health outcomes and efficiency
Partnership to target multiple serious diseases using real world data studies. -
News Spray drying specialist to invest €19 million in GMP facility expansion
Investment is in response to increased market for spray drying and capsule filling for dry powder inhalers. -
News Oak Therapeutics completes critical milestone in Phase I to develop oral dissolvable strip for TB
Comapny has created a novel formulation to produce a product prototype containing 300 mg of Isoniazid, that is both rapidly dissolving and mucoadhesive. -
News Oxford Genetics secures £7.5 million investment
Investment will fund a new office in Boston, US, an extension of its UK facility at the Oxford Science Park, and R&D capabilities to increase its intellectual property portfolio. -
News Champions Oncology collaborates with AstraZeneca to develop unique cohorts of PDX models
Models will be used in AstraZeneca's oncology R&D programs in breast and lung cancer. -
News RedHill Biopharma announces US commercialization agreement for FDA-approved GI product
Esomeprazole Strontium DR capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor, indicated for adults for the treatment of gastroesophageal reflux disease and other gastrointestinal conditions. -
News BMS and Pfizer to highlight commitment to reducing the risk of stroke at ECS Congress 2017
Eliquis clinical data include results from a Phase IV trial to be featured in late-breaking science sessions, -
News A plant-based delivery system for anti-cancer drugs
Study demonstrates that a complex consisting of tobacco mosaic virus and vcMMAE can kill cancer cells. -
News INNOVATIVE CONTINUOUS PELLETISING TECHNOLOGIES
Glatt Pharmaceutical Services, the CDMO division of Glatt offers its formulation and product development services using innovative direct pelletizing technologies to support you with tailored solutions. Some of the Technologies are described below.
... -
News Hikma statement on generic Advair Diskus
Company been able to clarify and resolve a number of the questions raised by the FDA. -
News Mylan finalizes settlement agreement on Medicaid rebate classification for EpiPen Auto-Injector
Mylan will reclassify EpiPen Auto-Injector for purposes of the Medicaid Drug Rebate Program and pay the rebate applicable to innovator products effective as of 1 April 2017. -
News Pfizer to adopt Orion cloud platform for computational chemistry
Orion's workflow tools will help Pfizer's efforts to deliver potential breakthrough therapies for patients. -
News Hikma announces new licensing agreement with Takeda for products in the MENA
Hikma granted the exclusive rights to manufacture and commercialise three of Takeda’s leading primary care product families. -
News Serialization software for FMD compliance
This month in Pharmaceutical Manufacturing and Packing Sourcer, Verify Brand’s CEO, Michael Howe, addresses how Europe’s Falsified Medicines Directive (FMD) not only provides health and safety benefits to patients, it also presents an opportunity ... -
News Evotec completes acquisition of Aptuit
Employees and capabilities will be integrated into Evotec's global drug discovery group to maximise commercial synergies. -
News Vectura signs global development agreement with Dynavax
Agreement convers the clinical application of Vectura's proprietary smart nebuliser technology to deliver Dynavax's investigational immunotherapeutic agent to lung cancer patients. -
News Metacrine collaborates on development of FGF1 variants for glucose lowering and improving insulin sensitivity
Novo Nordisk will have an option to license the FGF1 program upon achievement of certain research milestones. -
News Abcam and TTP Labtech collaborate to develop sol-R reagent kits
Assay-ready kits will incorporate fully-validated, industry-leading recombinant antibody technology for high throughput research. -
News The Great Hall of China: double digit growth at CPHI China
The Asian pharma event surpasses 55,000 visits with more than 10,000 overseas visits. -
News Bespoke filtration equipment enables pharma manufacturer to fulfil contract
Major pharma manufacturer delivers critical drugs to a leading children's hospital. -
News Cambridge Epigenetix and NuGEN Technologies combine leading technologies in epigenetics research
Co-exclusive global licence covers manufacture and integration of CEGX TrueMethyl technology for oxidative bisulfite sequencing with Targeted Methylation and NuGEN Ovation Methyl-Seq systems. -
News Shire submits lifitegrast MAA for treatment of dry eye disease in Europe
Lifitegrast, if approved, would be the first and only new class treatment to address the signs and symptoms of dry eye disease in adults in Europe. -
News Regeneron to discontinue development of suptavumab for respiratory syncytial virus
Phase III study fails to meet its primary endpoint. -
News Ionis to go it alone with Inotersen and IONIS-FB-L Rx after GSK decline
Inotersen on track for marketing authorization filings this year. -
News Fortress Biotech forms new subsidiary, Aevitas Therapeutics
Subsidiary to develop novel AAV gene therapy treatments for complement-mediated. -
News Kalytera submits Phase II study protocol to IRBs for cannabidiol in the prevention of GvHD
The Phase II study is designed to generate the pharmacokinetic and safety data, at multiple dose levels, that will be required by the FDA. -
News Tyme Technologies announces the issuance of two new platform patents
The two patents represent the next generation of SM-88, joining tyrosine and melanin into a potentially more potent combination. -
News FDA removes clinical hold on CEL-SCI’s Phase III head & neck cancer trial
The last FDA approved treatment for advanced primary head and neck cancer was over 50 years ago. -
News Experimental treatment for Niemann-Pick disease type C1 appears safe, effective
NIH-led clinical trial suggests that drug slows progression of rare neurological disease. -
News FDA approves liposome-encapsulated combination of daunorubicin-cytarabine for adults with AML
Vyxeos represents the first new chemotherapy advance in more than 40 years for these adults with AML. -
News Mylan launches Avonza in India
Company is first to offer innovative, reduced-dose HIV treatment in India. -
News CPHI India Report identifies two-tier manufacturing market and predicts increased acquisitions
CDSCO certification has improved international repute of India, but domestic companies call for urgent Government support to invest in API facilities. -
News SK Capital agrees to acquire Perrigo API business
Transaction is expected to close during Q4 2017, before which a new trade name will be selected for the Business. -
News Major progress in next generation medicines initiative
Juniper Pharma Services now has CrystecPharma’s supercritical fluid technology platform on-site. -
News TraceLink breaks new record for highest quarterly sales bookings in Q2 2017
Company also becomes the first solution provider to achieve 100 pharmaceutical and contract manufacturers live and ready for serialization. -
News Biotech sector will drive biggest advancements in decades on cancer treatments
Small nimble biotechs to introduce a ‘golden age’ of next generation therapies such as CAR-T, combination therapies, innate immune system approaches, and newer check-point inhibitors. -
News Sanofi files suit in the US to defend its patent rights on Lantus
Company alleges infringement of two patents. -
News NICE recommends Erbitux in combination with chemotherapy for the treatment of head and neck cancer
Decision secures access to Erbitux for new patients in England with oral cavity tumours. -
News ANGUS Life Sciences Expands U.S. Biotechnology Commercial Team
Addition of Five Regional Account Managers Enhances Focus on Addressing Specific Needs of Biotechnology and Pharmaceutical Manufacturers
ANGUS Life Sciences, a business of ANGUS Chemical Company (“ANGUS" or the “Company”) and the world’s onl... -
News SGS expands and increases capacity by 50% at its Lincolnshire, IL facility
Investment will increase the company's flexibility in meeting both existing and future customer demands. -
News Cambrex invests $24 million in new HPAPI manufacturing capacity at its Charles City, Iowa facility
Project also includes reconfigure the existing small-scale manufacturing area providing a single high-containment building to support early-stage development and manufacturing. -
News EIB backs German cancer therapy developer MagForce with up to EUR 35m
The company's NanoTherm therapy makes it possible to combat the tumour from within, while sparing surrounding healthy tissue. -
News Sanner invests in Bensheim production facility
14 new injection-molding machines and significant increase in efficiency and energy savings. -
News Impax announces settlement of contract litigation on Opana ER CII Extended-Release tablets
Contract dispute relates to an agreement entered into among Endo International, Penwest Pharmaceuticals and Impax. -
News “INSPAIR, A SMART SENSOR FOR INHALERS”
The smart sensor to convert inhalers into connected devices to help patients with Asthma or Chronic Obstructive Pulmonary Diseases (COPD). -
News Mylan receives tentative approval for "TLD" under PEPFAR
Mylan's TLD is the first fixed-dose combination of its kind to be offered to patients being treated for HIV/AIDS. -
News NCI study identifies essential genes for cancer immunotherapy
This knowledge could speed the development of a new category of drugs. -
News New controlled nucleation resource center
SP Scientifc's ControLyo Central is a suite of online resources to help freeze dried parenterals manufacturers. -
News Insanitary conditions bring Isomeric Pharmacy Solutions to a halt
Federal judge enters consent decree against outsourcing facility Isomeric Pharmacy Solutions. -
News AbbVie's Mavyret receives FDA approval for the treatment of chronic hepatitis C
FDA approval is supported by an overall 98% cure rate in patients who received the recommended duration of treatment . -
News Captek Softgel International acquires J+D Labs
J+D Labs’ extensive experience manufacturing a wide-range of softgels, specialized tablets, capsules, and powder formulations complements Captek’s offerings. -
News NICE approves Abraxane for pancreatic cancer
Life-extending pancreatic cancer medicine to be made available immediately on the NHS. -
News Lonza acquires Micro-Macinazione to create the leader in micronization capacity and capabilities
Bolt-on acquisition adds value to other areas of Lonza’ business, including Health & Nutrition ingredients and excipients. -
News The new KTP 590X rotary press sharpens Romaco Kilian’s effervescents profile
Romaco will additionally show Innojet process technology and Kilian services at POWTECH. -
News BMS to acquire IFM Therapeutics to strengthen oncology pipeline focus on innate immunity
Gains full rights to IFM’s preclinical STING and NLRP3 agonist programs focused on enhancing the innate immune response for treating cancer. -
News Biopharma stages a strong recovery over the first half even as M&A deals disappoint
EP Vantage releases half-year reviews of pharma & biotech and medtech performance. -
News FDA grants Genentech’s Alecensa Priority Review
Designation given for initial treatment of people with ALK-positive lung cancer. -
News IDT launches first Cas9 enzyme that drastically reduces CRISPR off-target effects without significant loss of on-target activity
The launch represents a major step towards therapeutic use of CRISPR. -
News BMS receives FDA approval for Opdivo Injection for metastatic colorectal cancer
Approval based on CheckMate -142, in which Opdivo demonstrated an objective response rate of 28% among patients who received prior treatment with a fluoropyrimidine, oxaliplatin, and irinotecan. -
News UBM and Restec discontinue Russia partnership
RESTEC to organise a stand-alone IPhEB exhibition in Russia from 2018 onwards. -
News Baxter completes acquisition of Claris Injectables, expanding generic injectable medicines portfolio
Baxter plans to invest in further increasing Claris Injectables’ capacity and capabilities, including adding new aseptic manufacturing and lyophilization. -
News TraceLink expands offering with ROC IT Solutions acquisition
Company can now offer solutions for serialized receiving, picking, shipping, returns, deactivation, aggregation, de-aggregation, label printing and tag management of pharmaceutical products. -
News Growing and going beyond. Alfa Wasserman comes Alfasigma
From the aggregation of Alfa Wassermann and Sigma Tau comes Alfasigma, a new company, also in Contract Manufacturing, which inherits the values that have always inspired Alfa Wassermann Contract Manufacturing: quality, technology, versatility and relia... -
News Cherwell publishes Cleanroom Decontamination Guide
Guide aims to help the operator understand the complex protocols and heavily regulated procedures associated with pharmaceutical cleanrooms. -
News Amgen submits sBLA for Prolia in glucocorticoid-induced osteoporosis
Results from the Phase III study included in the sBLA submission showed that treatment with Prolia for 12 months led to statistically significant greater gains in BMD at the lumbar spine and total hip compared to risedronate. -
News STA Pharmaceutical merges with WuXi¹s Pharmaceutical Development Services Division
The merger enables STA to advance NCEs from pre-clinical stage to New Drug Application and to market faster and more efficiently for pharma and biotech customers. -
News BMS and Clovis Oncology announce a broad clinical collaboration to evaluate combination of Opdivo and Rubraca
Pivotal Phase III trials planned for 2017 will evaluate Rubraca + Opdivo, Rubraca as monotherapy, and Opdivo as monotherapy in first line maintenance treatment for advanced ovarian and advanced triple-negative breast cancers. -
News Arch Biopartners' GMP manufacturing of AB569 on schedule
Dalton Pharma Services is preparing glass vials in three varying dose formulations for the clinical kits needed to support the Phase I safety trial for AB569 at the CVAMC later this year. -
News Boehringer starts clinical study on interchangeability between adalimumab biosimilar candidate and US-formulated Humira
First study in the US to investigate an interchangeability designation for an adalimumab biosimilar candidate. -
News AstraZeneca and Merck establish oncology collaboration
Collaboration aims to maximize the potential of PARP and MEK inhibitors in combination with PD-L1/PD-1 medicines, based on growing scientific evidence that these combinations offer new potential for the treatment of a range of tumor types. -
News Torbay Pharmaceuticals opens new £26 million pharmaceutical manufacturing unit
The new facilities enable to company to further grow and flourish. -
News PCI Delivers ALUNBRIG™ Commercial Launch for Takeda
First Molecule to Complete the Development-to-Launch Cycle within PCI’s Contained Manufacturing Facility.PCI Pharma Services has announced its first client product to move from clinical development to US commercial launch.
-
News Pall introduces proprietary bioreactor control system
The mPath bioreactor control system is the first to be developed and delivered by a technology supplier specifically for their product line, allowing full access to bioreactor capabilities that current commercial solutions cannot provide. -
News CPHI Annual Reports - how accurate were they 5 years on?
The CPHI predictions foresaw advancement in QbD, continuous processing, and a dramatic rise in FDA warning letters. -
News Bavarian Nordic and Janssen to develop vaccine regimens against HIV-1 and Hepatitis B
Deal builds on ongoing collaboration to develop vaccines for Human Papillomavirus (HPV) and Ebola. -
News Valeant launches Siliq Injection in US
Dermatology unit is rebranded Ortho Dermatologics. -
News Lonza innovation to transform biological development and manufacturing
Company launches Ibex innovation in biological development and manufacturing. -
News New leakproof vials offer enhanced sample and user safety
Thermo's Samco Clicktainer vials provide secure and reliable sample collection and transport. -
News Mylan receives WHO Prequalification for generic Sovaldi
First generic prequalification for sofosbuvir tablets. -
News BMS's Orencia receives second EC approval in less than a year
New approval for treatment of active psoriatic arthritis (PsA). -
News Vertex and Concert Pharmaceuticals complete asset purchase agreement for CTP-656
Vertex now has worldwide development and commercialization rights to CTP-656 and other assets related to the treatment of cystic fibrosis. -
News Artificial intelligence to discover drugs in a multi-year multimillion dollar deal
AI thought to have massive potential to reduce the cost associated with the discovery of new drugs. -
News New research highlights lack of confidence in serialization preparations
40% of industry professionals admit they are not clear about the global requirements for serialization. -
News STA signs 5-year supply agreement with TESARO
STA will provide supplies of certain starting and intermediate materials for the recently launched Zejula. -
News Merck launches Remicade biosimilar for all eligible indications, in the US
The biosimilar's list price will represent a 35% discount to the current list price of Remicade. -
News Long-acting injection to remove daily dosing burden for HIV patients?
Study results showed that long-acting cabotegravir and rilpivirine maintained viral suppression. -
News Lilly backs Nektar Therapeutics' novel immunological therapy
NKTR-358 has the potential to treat a number of autoimmune and other chronic inflammatory conditions. -
News Novartis receives positive CHMP opinion for Rydapt
If approved, Rydapt would represent the first targeted treatment for newly diagnosed FLT3-mutated AML in the EU. -
News GSK receives FDA approval for a new self-injectable formulation of Benlysta
The approval marks the first subcutaneous self-injection treatment option for patients with systemic lupus erythematosus. -
News Boehringer Ingelheim breaks ground on $217 million expansion of Fremont, California manufacturing facility
Expansion will triple capacity, add nearly 300 new jobs. -
News Merck and Pfizer collaborate with Corning to modernize pharmaceutical glass packaging
Collaborations result in development of Corning Valor Glass. -
News Biohit Acetium® lozenge is a highly effective means to stop smoking – results confirmed in a new large-scale trial
The second smoking intervention study started in 2016 with Biohit Acetium lozenge has been completed confirming the efficacy of Acetium lozenge as an effective way to assist in smoking cessation. This new trial was designed to be adequately powered ... -
News NEWGUARD: SAFER PREFILLED SYRINGES & FEWER CHANGES
Given the rising number of guidelines to reduce risks of needlestick injuries, pharmaceutical companies have been searching for systems to ensure safe syringe use. Despite great innovations, adopting new safety systems has always been a trade-off betwe... -
News Recipharm and LIDDS establish industrial manufacturing capabilities for a novel prostate cancer product
GMP Manufacturing line industrialised according to a unique process invented by LIDDS, involving the installation of novel equipment that is new to the pharmaceutical industry. -
News Catalent and academia on quest to better understand pediatric drug formulation and delivery challenges
Goal of the collaboration is to identify therapies and diseases for which there is a high need for pediatric-friendly formulations. -
News LifeArc negotiates exclusive licence deal with Nemysis for oral iron supplement technology
IHAT, a novel synthetic material, is a commercially viable alternative to ferrous salts for iron supplementation. -
News Positive results from 12-month Phase III safety study of Revefenacin in patients with COPD
These data, combined with positive results from two Phase III efficacy studies, support NDA filing planned for fourth quarter of 2017. -
News COVIS TAPS VERIFY AHEAD OF THE EXTENDED DSCSA MANDATE
This month in Outsource Pharma online, Michael Howe, CEO of Verify Brand, a Minneapolis-based serialization software provider, addresses that even though the DSCSA deadline was extended, many pharma manufacturers, such as Verify Brand’s client Cov... -
News * NEW * PRESERVATIVE FREE CROSSED LINKED HYALURONIC ACID DROPS
World first preservative-free eye drops with cross-linked Hyaluronic AcidCross-linked Hyaluronic Acid is a form of Hyaluronic Acid more stable and effective which increases:- Moisturizing properties - Long-term effectiveness- Viscosity and physica... -
News Onyx helps to accelerate TopiVert’s compounds to clinic
With support from the CRO, TopiVert has been able to accelerate scale-up and produce GMP batches, which are now being used in clinical trials. -
News GSK delivers double-edged sword
Company announces investments, the sale of several products and a proposal to close a UK manufacturing site. -
News South Korean pharma rapidly becoming manufacturing export hub
Overseas buyers at CPHI Korea double in the past 2 years. -
News VIALS MACHINERIES
TWO MORE VIALS MAKING MACHINERIES, FOR AN INCREASED MANUFACTURING CAPACITY -
News Ordesa Catalogue
ordesa corporative brochure -
News ordesa catalogue
ordesa corporative brochure -
News Transfer technology expert expands US presence following multi-million-pound investment
Investment follows demand for the company's AseptiSafe and PharmaSafe product ranges, which transfer APIs in small- and large-scale pharmaceutical manufacturing environments. -
News FDA approves new treatment to reduce the risk of breast cancer returning
Nerlynx is the first extended adjuvant therapy for patients with HER2-positive breast cancer. -
News Shire expands broad monoclonal antibody research platform
Shire obtains worldwide license to pursue development and commercialization of a novel, potentially differentiated, pre-clinical bi-specific antibody candidate for Hemophilia A. -
News Amgen and Array BioPharma announce preclinical license and collaboration agreement in inflammation
Array to advance preclinical program for autoimmune disorders; Amgen responsible for clinical development and worldwide commercialization. -
News Technology adoption fuels growth for pharma tech firm
Company has experienced double digit growth across its automation, MES and managed services offering. -
News Catalent launches new OptiForm Solution Suite
The service offers quick and efficient path from late-stage discovery to Phase I clinical trials.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance